Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 3
2017 1
2018 3
2019 2
2020 2
2021 3
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.
Roazzi L, Patelli G, Bencardino KB, Amatu A, Bonazzina E, Tosi F, Amoruso B, Bombelli A, Mariano S, Stabile S, Porta C, Siena S, Sartore-Bianchi A. Roazzi L, et al. Among authors: bonazzina e. Clin Colorectal Cancer. 2024 Feb 16:S1533-0028(24)00006-9. doi: 10.1016/j.clcc.2024.02.001. Online ahead of print. Clin Colorectal Cancer. 2024. PMID: 38519391 Review.
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers.
Mauri G, Patelli G, Roazzi L, Valtorta E, Amatu A, Marrapese G, Bonazzina E, Tosi F, Bencardino K, Ciarlo G, Mariella E, Marsoni S, Bardelli A, Bonoldi E, Sartore-Bianchi A, Siena S. Mauri G, et al. Among authors: bonazzina e. J Clin Pathol. 2024 Feb 13:jcp-2023-209341. doi: 10.1136/jcp-2023-209341. Online ahead of print. J Clin Pathol. 2024. PMID: 38350716 Free article.
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer.
Patelli G, Mauri G, Tosi F, Amatu A, Bencardino K, Bonazzina E, Pizzutilo EG, Villa F, Calvanese G, Agostara AG, Stabile S, Ghezzi S, Crisafulli G, Di Nicolantonio F, Marsoni S, Bardelli A, Siena S, Sartore-Bianchi A. Patelli G, et al. Among authors: bonazzina e. Clin Cancer Res. 2023 Nov 14;29(22):4530-4539. doi: 10.1158/1078-0432.CCR-23-0079. Clin Cancer Res. 2023. PMID: 37436743 Free PMC article. Review.
Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea.
Mauri G, Pedrani M, Ghezzi S, Bencardino K, Mariano S, Bonazzina E, Serra F, Pedrazzoli P, Caccialanza R, Cavestro GM, Siena S, Artale S, Sartore-Bianchi A. Mauri G, et al. Among authors: bonazzina e. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e885-e889. doi: 10.1136/spcare-2023-004203. BMJ Support Palliat Care. 2024. PMID: 37344158 Free PMC article.
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: bonazzina e. Front Oncol. 2023 Mar 28;13:1147497. doi: 10.3389/fonc.2023.1147497. eCollection 2023. Front Oncol. 2023. PMID: 37056342 Free PMC article.
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, Bencardino K, Tosi F, Bonazzina E, Bonoldi E, Bardelli A, Siena S, Sartore-Bianchi A. Mauri G, et al. Among authors: bonazzina e. Front Oncol. 2022 Nov 7;12:1030232. doi: 10.3389/fonc.2022.1030232. eCollection 2022. Front Oncol. 2022. PMID: 36419886 Free PMC article.
Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
Patelli G, Vaghi C, Tosi F, Mauri G, Amatu A, Massihnia D, Ghezzi S, Bonazzina E, Bencardino K, Cerea G, Siena S, Sartore-Bianchi A. Patelli G, et al. Among authors: bonazzina e. Target Oncol. 2021 May;16(3):413. doi: 10.1007/s11523-021-00812-7. Target Oncol. 2021. PMID: 33788137 Free PMC article. No abstract available.
21 results